About the Company
As The Spatial Biology Company®, Akoya Biosciences’ mission is to bring context to the world of biology and human health through the power of spatial phenotyping. The company offers comprehensive single-cell imaging solutions that allow researchers to phenotype cells with spatial context and visualize how they organize and interact to influence disease progression and treatment response. Akoya offers two distinct solutions, the CODEX® and Phenoptics™ platforms, to serve the diverse needs of researchers across discovery, translational and clinical research.
Fundamental Data and Insider Transactions (Quarterly data) Full Screen
Loading the fundamentals chart...
Latest $AKYA News
Institutions own 23% of Akoya Biosciences, Inc. (NASDAQ:AKYA) shares but private equity firms control 49% of the company
A look at the shareholders of Akoya Biosciences, Inc. ( NASDAQ:AKYA ) can tell us which group is most powerful. We ...
Akoya Biosciences, Inc. (AKYA) Q3 2022 Earnings Call Transcript
Good day and thank you for standing by. Welcome to the Akoya Biosciences Third Quarter 2022 Earnings Conference Call. At this time, all participants are in a listen-only mode. After the speakers ...
Akoya Biosciences Inc. (NASDAQ: AKYA) Up 4.42%: This Is What Analysts Are Now Forecasting
Akoya Biosciences Inc. (NASDAQ:AKYA) price on Wednesday, November 30, rose 4.42% above its previous day’s close as an upside momentum from buyers pushed the stock’s value to $12.98. A look at the ...
Akoya Biosciences Inc.
Stocks: Real-time U.S. stock quotes reflect trades reported through Nasdaq only; comprehensive quotes and volume reflect trading in all markets and are delayed at least 15 minutes. International ...
Akoya Reports Record Revenue with 40% YoY Growth in the Third Quarter and Raises Full Year 2022 Revenue Guidance
MARLBOROUGH, Mass., Nov. 07, 2022 (GLOBE NEWSWIRE) -- Akoya Biosciences, Inc. (Nasdaq: AKYA) (“Akoya”), The Spatial Biology Company®, today announced its ...
Akoya Biosciences Launches PhenoCode Signature Panels to Accelerate Development of Predictive Biomarkers for Cancer Immunotherapy
Nov. 07, 2022 (GLOBE NEWSWIRE) -- Akoya Biosciences, Inc., (Nasdaq: AKYA), The Spatial Biology Company®, today announced the launch of PhenoCode™ Signature Panels for high-throughput spatial ...
Loading the latest forecasts...